Literature DB >> 10740290

Elucidating cell signaling mechanisms using antisense technology.

E Koller1, W A Gaarde, B P Monia.   

Abstract

Many diseases result from defects in cell signaling. Achieving an in-depth understanding of the complex mechanisms by which cells transduce extracellular signals into cellular responses in both normal and diseased systems is a crucial step in the discovery of more effective drugs to treat human diseases. Traditional approaches for studying cell signaling have some limitations. Antisense oligonucleotides represent a novel approach for studying signal transduction processes that offers significant advantages in terms of specificity and versatility. This article reviews the opportunities that antisense oligonucleotides offer for the study of signal transduction pathways and identification of inhibitors of these pathways for drug development.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 10740290     DOI: 10.1016/s0165-6147(00)01448-6

Source DB:  PubMed          Journal:  Trends Pharmacol Sci        ISSN: 0165-6147            Impact factor:   14.819


  9 in total

1.  NMR solution structure of a parallel LNA quadruplex.

Authors:  Antonio Randazzo; Veronica Esposito; Oliver Ohlenschläger; Ramadurai Ramachandran; Luciano Mayola
Journal:  Nucleic Acids Res       Date:  2004-06-04       Impact factor: 16.971

Review 2.  [Viral and nonviral gene therapy for treatment of retinal diseases].

Authors:  J Neidhardt; K Wycisk; B Klöckener-Gruissem
Journal:  Ophthalmologe       Date:  2005-08       Impact factor: 1.059

3.  The application of antisense technology to medicine.

Authors:  R Re
Journal:  Ochsner J       Date:  2000-10

Review 4.  Recent advances in peptide nucleic acid for cancer bionanotechnology.

Authors:  Jun-Chen Wu; Qing-Chun Meng; Hong-Mei Ren; Hong-Tao Wang; Jie Wu; Qi Wang
Journal:  Acta Pharmacol Sin       Date:  2017-04-17       Impact factor: 6.150

5.  Essential role of p38gamma in K-Ras transformation independent of phosphorylation.

Authors:  Jun Tang; Xiaomei Qi; Dan Mercola; Jiahuai Han; Guan Chen
Journal:  J Biol Chem       Date:  2005-04-25       Impact factor: 5.157

Review 6.  Human Protein Tyrosine Phosphatase 1B (PTP1B): From Structure to Clinical Inhibitor Perspectives.

Authors:  Rongxing Liu; Cécile Mathieu; Jérémy Berthelet; Wenchao Zhang; Jean-Marie Dupret; Fernando Rodrigues Lima
Journal:  Int J Mol Sci       Date:  2022-06-24       Impact factor: 6.208

7.  Therapeutic potential of mipomersen in the management of familial hypercholesterolaemia.

Authors:  Carmen Gelsinger; Elisabeth Steinhagen-Thiessen; Ursula Kassner
Journal:  Drugs       Date:  2012-07-30       Impact factor: 9.546

Review 8.  Antisense therapy in clinical oncology: preclinical and clinical experiences.

Authors:  Ingo Tamm; Mandy Wagner
Journal:  Mol Biotechnol       Date:  2006-07       Impact factor: 2.860

Review 9.  Morpholino antisense oligonucleotides: tools for investigating vertebrate development.

Authors:  D R Corey; J M Abrams
Journal:  Genome Biol       Date:  2001-04-26       Impact factor: 13.583

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.